Javascript must be enabled to continue!
Research on the Preparation Process of Mahuang Xixin Fuzi Decoction Granules
View through CrossRef
Abstract
Objective The objective of this study was to investigate the preparation process of Mahuang Xixin Fuzi decoction granules based on the clinical pharmacological effects of the classic formulas and to control the quality of the product.
Methods An orthogonal experimental design was used, with extraction yield and transfer rate of key ingredients as evaluation indicators, to optimize the extraction process of Mahuang Xixin Fuzi decoction. The granulation process was optimized based on indicators such as granule formation rate, dissolution rate, and moisture absorption rate.
Results The optimal extraction process for Mahuang Xixin Fuzi decoction was determined as the following: using 10 times the amount of water to soak for 30 minutes, extracting three times, each for 60 minutes, with a concentrated extract relative density of 1.3 g/mL. A mixture of dextrin and starch at a 1:2 ratio was used as a binder for wet granulation. The granule formation rate, dissolution time, and dilution rate of three repeated batches showed relative standard deviation (RSD) values of 1.48, 2.83, and 1.55%.
Conclusion This method is stable and feasible, providing valuable data for the industrial production of Mahuang Xixin Fuzi decoction granules and further research on this formulation.
Georg Thieme Verlag KG
Title: Research on the Preparation Process of Mahuang Xixin Fuzi Decoction Granules
Description:
Abstract
Objective The objective of this study was to investigate the preparation process of Mahuang Xixin Fuzi decoction granules based on the clinical pharmacological effects of the classic formulas and to control the quality of the product.
Methods An orthogonal experimental design was used, with extraction yield and transfer rate of key ingredients as evaluation indicators, to optimize the extraction process of Mahuang Xixin Fuzi decoction.
The granulation process was optimized based on indicators such as granule formation rate, dissolution rate, and moisture absorption rate.
Results The optimal extraction process for Mahuang Xixin Fuzi decoction was determined as the following: using 10 times the amount of water to soak for 30 minutes, extracting three times, each for 60 minutes, with a concentrated extract relative density of 1.
3 g/mL.
A mixture of dextrin and starch at a 1:2 ratio was used as a binder for wet granulation.
The granule formation rate, dissolution time, and dilution rate of three repeated batches showed relative standard deviation (RSD) values of 1.
48, 2.
83, and 1.
55%.
Conclusion This method is stable and feasible, providing valuable data for the industrial production of Mahuang Xixin Fuzi decoction granules and further research on this formulation.
Related Results
Uncovering Modern Clinical Applications of Fuzi and Fuzi-Based Formulas: A Nationwide Descriptive Study With Market Basket Analysis
Uncovering Modern Clinical Applications of Fuzi and Fuzi-Based Formulas: A Nationwide Descriptive Study With Market Basket Analysis
Background: As time evolved, traditional Chinese medicine (TCM) became integrated into the global medical system as complementary treatments. Some essential TCM herbs started to pl...
Xixin Decoction May Treat Vascular Dementia by Modulating the NPTX2/C1q/C3 Complement Pathway
Xixin Decoction May Treat Vascular Dementia by Modulating the NPTX2/C1q/C3 Complement Pathway
ABSTRACT
Vascular dementia (VaD) is a type of dementia that results from brain injury caused by cerebrovascular disease or vascular risk factors. Accumulating evi...
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
Objectives
To detect the effect of Sini Decoction on the expression of Sirt-1 and eNOS in EAhy926 cell injured by homocysteine.
...
A randomized controlled trial study protocol of modified Mahuang-Fuzi-Xixin decoction in the treatment of patients with mild bronchial asthma during acute exacerbation
A randomized controlled trial study protocol of modified Mahuang-Fuzi-Xixin decoction in the treatment of patients with mild bronchial asthma during acute exacerbation
Abstract
Introduction:
These years, due to dissatisfaction with western medicine treatments, traditional Chinese medicine (TCM) becomes a main tr...
Winyanghuayin Decoction and Xiaoqinglong Decoction Treatment Airway Inflammation of Cold Asthma Through PI3K-mTOR Signal Pathway
Winyanghuayin Decoction and Xiaoqinglong Decoction Treatment Airway Inflammation of Cold Asthma Through PI3K-mTOR Signal Pathway
Abstract
Background: Airway inflammation plays a pivotal role in cold asthma. Winyanghuayin decoction and Xiaoqinglong decoction can significantly improve airway inflammati...
Observation on the Efficacy of Self-formulated Huatan Chushi Zhuyu Decoction in the Treatment of Adenoid Hypertrophy in Children and Literature Research on Traditional Chinese Medicine Treatment
Observation on the Efficacy of Self-formulated Huatan Chushi Zhuyu Decoction in the Treatment of Adenoid Hypertrophy in Children and Literature Research on Traditional Chinese Medicine Treatment
To observe the clinical efficacy of the self-formulated Huatan Chushi Zhuyu Decoction (HCZ Decoction) combined with basic Western medical treatment in children with moderate to sev...
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
Objectives
To detect the effect of Sini Decoction on the expression of Caveolin-1 and eNOS in EAhy926 cell injured by homocysteine.
...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...

